Aspen Aerogels, Inc.
General ticker "ASPN" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $677.7M (TTM average)
Aspen Aerogels, Inc. follows the US Stock Market performance with the rate: 10.3%.
Estimated limits based on current volatility of 1.8%: low 3.40$, high 3.62$
Factors to consider:
- Total employees count: 554 (+1.1%) as of 2024
- US accounted for 57.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Net losses, Foreign operations risks, Production capacity, Operational and conduct risks, Economic downturns and volatility
- Current price 46.2% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.75$, 14.91$]
- 2025-12-31 to 2026-12-31 estimated range: [5.14$, 11.51$]
Financial Metrics affecting the ASPN estimates:
- Positive: with PPE of 25.3 at the end of fiscal year the price was very low
- Positive: 7.86 < Operating profit margin, % of 12.05
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 1.47
- Positive: -14.38 < Investing cash flow per share per price, % of -9.17
- Positive: Shareholder equity ratio, % of 68.67 > 63.39
- Positive: 5.52 < Industry operating cash flow per share per price (median), % of 7.86
- Positive: 0.33 < Operating cash flow per share per price, % of 4.84
- Positive: Industry operating profit margin (median), % of 11.88 > 9.92
- Negative: Industry inventory ratio change (median), % of 0.90 > 0.28
Short-term ASPN quotes
Long-term ASPN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $180.36MM | $238.72MM | $452.70MM |
| Operating Expenses | $259.61MM | $287.92MM | $398.16MM |
| Operating Income | $-79.25MM | $-49.20MM | $54.53MM |
| Non-Operating Income | $-3.49MM | $3.39MM | $-39.45MM |
| Interest Expense | $5.11MM | $5.33MM | $7.55MM |
| R&D Expense | $16.93MM | $16.36MM | $18.05MM |
| Income(Loss) | $-82.74MM | $-45.81MM | $15.09MM |
| Taxes | $0.00MM | $0.00MM | $1.71MM |
| Profit(Loss)* | $-82.74MM | $-45.81MM | $13.38MM |
| Stockholders Equity | $447.44MM | $488.06MM | $614.71MM |
| Inventory | $22.54MM | $39.19MM | $47.55MM |
| Assets | $643.42MM | $703.05MM | $895.14MM |
| Operating Cash Flow | $-94.40MM | $-42.61MM | $45.55MM |
| Capital expenditure | $177.97MM | $175.46MM | $86.26MM |
| Investing Cash Flow | $-177.97MM | $-175.46MM | $-86.26MM |
| Financing Cash Flow | $478.37MM | $75.48MM | $122.02MM |
| Earnings Per Share** | $-2.10 | $-0.66 | $0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.